This report describes a rare case of lung adenocarcinoma with concurrent TP53, MET exon 14 skipping mutations and JAK2 V617F mutations, accompanied by marked preoperative thrombocytosis that decreased following tumor resection. Here, MET is linked to thrombocytosis disease.